Do trichothecene mycotoxins inhibit protein synthesis and trigger downstream stress responses?

Trichothecenes are a chemically diverse group of fungal toxins. Their core molecular action—blocking eukaryotic ribosome-mediated protein synthesis—is well established; downstream oxidative, intestinal, and immune effects are more dependent on the individual toxin, dose, and experimental setting.

Mechanistic and cellular evidence

• Trichothecenes bind non-covalently at an rRNA-defined site in the 60S ribosomal peptidyl-transferase center, disrupting translation. Thus, “inhibit ribosomal protein synthesis” is most precisely interpreted as inhibition of cellular protein synthesis by ribosomes.
• Nivalenol (NIV) causes polysome breakdown, consistent with impaired translation initiation. Ribosome targeting can also initiate a ribotoxic-stress response involving MAPK signaling.
• In human HCT-8 intestinal epithelial cells, NIV increased eIF2α phosphorylation within minutes. In rat IEC-6 intestinal epithelial cells, NIV induced apoptosis at concentrations ≥5 μM.

Oxidative stress and intestinal injury

• For deoxynivalenol (DON) and NIV, cell and animal studies show increased reactive oxygen species and oxidative/nitrosative stress. Proposed mediators include NADPH oxidase activation, calcium dysregulation, NF-κB, and Nrf2 signaling; NIV may be more pro-oxidant than DON and can augment DON effects in combined exposures.
• DON has direct experimental support for impaired intestinal-barrier function, including reduced transepithelial resistance, increased permeability, and altered tight-junction protein abundance or localization. Comparable direct barrier evidence for NIV is limited.

Immune effects and clinical interpretation

• DON and NIV can increase inflammatory mediators—including TNF-α, iNOS/COX-2, and caspase-1/IL-1β-associated responses—in intestinal-cell models, particularly with combined exposure or inflammatory stimuli. This supports context-dependent inflammatory modulation, rather than a uniform clinical immune disorder.

Bottom line

• The translation-inhibition claim is strongly supported. Oxidative stress and intestinal barrier injury are supported for selected congeners, especially DON and NIV, primarily in cellular and animal models. Immune dysregulation is biologically plausible but remains congener-, context-, and exposure-dependent, without direct human causal evidence for these downstream outcomes.